ClinicalTrials.Veeva

Menu

The Glycaemic Index of Manuka Honey

W

Waiariki Institute of Technology

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Manuka Honey

Study type

Interventional

Funder types

Other

Identifiers

NCT01615588
Manuka GI Study

Details and patient eligibility

About

Five high methylglyoxal (460-667 mg/kg) Manuka honey samples were selected from different geographical locales around the North Island of New Zealand and tested for glycaemic index (GI) in 10 healthy volunteers in a single-blinded, randomised study. Participants were fed honey containing 25g of available carbohydrate in 200 ml water and the blood glucose responses measured (area under the curve; AUC) and compared to that of 25 g of available carbohydrate from glucose.

Enrollment

10 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy (Body mass index (BMI) 20-25)
  • non-smoking
  • aged between 18-45 years
  • absence of diabetes or chronic illness
  • not taking any medications.

Exclusion criteria

  • currently dieting
  • suffering from illness or chronic disease
  • currently taking medication
  • smokers (including recreational)
  • outside healthy BMI range

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

10 participants in 1 patient group

honey
Experimental group
Description:
Manuka honey
Treatment:
Dietary Supplement: Manuka Honey

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems